OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prostate cancer vaccines in combination with additional treatment modalities
Matthew A. Uhlman, Megan T. Bing, David M. Lubaroff
Immunologic Research (2014) Vol. 59, Iss. 1-3, pp. 236-242
Closed Access | Times Cited: 15
Matthew A. Uhlman, Megan T. Bing, David M. Lubaroff
Immunologic Research (2014) Vol. 59, Iss. 1-3, pp. 236-242
Closed Access | Times Cited: 15
Showing 15 citing articles:
Immune Infiltration and Prostate Cancer
Amy Strasner, Michael Karin
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 177
Amy Strasner, Michael Karin
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 177
Recent advances and future perspectives in the therapeutics of prostate cancer
Ganji Lakshmi Varaprasad, Vivek Gupta, K. Satya Prasad, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Ganji Lakshmi Varaprasad, Vivek Gupta, K. Satya Prasad, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Translational research in oncology—10 years of progress and future prospects
James H. Doroshow, Shivaani Kummar
Nature Reviews Clinical Oncology (2014) Vol. 11, Iss. 11, pp. 649-662
Closed Access | Times Cited: 80
James H. Doroshow, Shivaani Kummar
Nature Reviews Clinical Oncology (2014) Vol. 11, Iss. 11, pp. 649-662
Closed Access | Times Cited: 80
Inflammation in Prostatic Hyperplasia and Carcinoma—Basic Scientific Approach
Božo Krušlin, Davor Tomas, Tihana Džombeta, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 65
Božo Krušlin, Davor Tomas, Tihana Džombeta, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 65
Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer
Mohammad‐Javad Sanaei, Loghman Salimzadeh, Nader Bagheri
Journal of Leukocyte Biology (2019) Vol. 107, Iss. 1, pp. 43-56
Closed Access | Times Cited: 33
Mohammad‐Javad Sanaei, Loghman Salimzadeh, Nader Bagheri
Journal of Leukocyte Biology (2019) Vol. 107, Iss. 1, pp. 43-56
Closed Access | Times Cited: 33
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions
Fernando López‐Campos, Pablo Gajate, Nuria Romero-Laorden, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 537-537
Open Access | Times Cited: 16
Fernando López‐Campos, Pablo Gajate, Nuria Romero-Laorden, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 537-537
Open Access | Times Cited: 16
Evidence of epithelial–mesenchymal transition in canine prostate cancer metastasis
Carlos Eduardo Fonseca‐Alves, Priscila Emiko Kobayashi, Luis Gabriel Rivera Calderón, et al.
Research in Veterinary Science (2015) Vol. 100, pp. 176-181
Closed Access | Times Cited: 25
Carlos Eduardo Fonseca‐Alves, Priscila Emiko Kobayashi, Luis Gabriel Rivera Calderón, et al.
Research in Veterinary Science (2015) Vol. 100, pp. 176-181
Closed Access | Times Cited: 25
From Bench to Bedside: Immunotherapy for Prostate Cancer
Brian Wan-Chi Tse, Lidija Jovanovic, Colleen C. Nelson, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 23
Brian Wan-Chi Tse, Lidija Jovanovic, Colleen C. Nelson, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 23
Oncolytic virotherapy for urological cancers
Zahid M. Delwar, Kaixin Zhang, Paul S. Rennie, et al.
Nature Reviews Urology (2016) Vol. 13, Iss. 6, pp. 334-352
Closed Access | Times Cited: 19
Zahid M. Delwar, Kaixin Zhang, Paul S. Rennie, et al.
Nature Reviews Urology (2016) Vol. 13, Iss. 6, pp. 334-352
Closed Access | Times Cited: 19
Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA–DR transgenic mouse model of prostate cancer
Vladimir Riabov, Irina Tretyakova, Richard B. Alexander, et al.
Vaccine (2015) Vol. 33, Iss. 41, pp. 5386-5395
Open Access | Times Cited: 14
Vladimir Riabov, Irina Tretyakova, Richard B. Alexander, et al.
Vaccine (2015) Vol. 33, Iss. 41, pp. 5386-5395
Open Access | Times Cited: 14
Natriuretic Peptides: The Case of Prostate Cancer
Letizia Mezzasoma, Matthew J. Peirce, Alba Minelli, et al.
Molecules (2017) Vol. 22, Iss. 10, pp. 1680-1680
Open Access | Times Cited: 11
Letizia Mezzasoma, Matthew J. Peirce, Alba Minelli, et al.
Molecules (2017) Vol. 22, Iss. 10, pp. 1680-1680
Open Access | Times Cited: 11
Clinical Decision Making
C. Rory Goodwin, Nancy Abu-Bonsrah, Mark H. Bilsky, et al.
Spine (2016) Vol. 41, Iss. 20, pp. S171-S177
Closed Access | Times Cited: 10
C. Rory Goodwin, Nancy Abu-Bonsrah, Mark H. Bilsky, et al.
Spine (2016) Vol. 41, Iss. 20, pp. S171-S177
Closed Access | Times Cited: 10
Comparing the frequency of CD33+ pSTAT3+ myeloid‐derived suppressor cells and IL‐17+ lymphocytes in patients with prostate cancer and benign prostatic hyperplasia
Mohammad‐Javad Sanaei, Fatemeh Taheri, Masoud Heshmati, et al.
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2086-2095
Closed Access | Times Cited: 8
Mohammad‐Javad Sanaei, Fatemeh Taheri, Masoud Heshmati, et al.
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2086-2095
Closed Access | Times Cited: 8
The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study
Bao-Chi Chang, Shyh‐Jen Wang
Human Vaccines & Immunotherapeutics (2015) Vol. 11, Iss. 3, pp. 789-794
Open Access | Times Cited: 5
Bao-Chi Chang, Shyh‐Jen Wang
Human Vaccines & Immunotherapeutics (2015) Vol. 11, Iss. 3, pp. 789-794
Open Access | Times Cited: 5
Immunotherapeutic strategies and immunotherapy resistance in prostate cancer
Arunima Deb, Neel Patel, Palak A. Patel, et al.
Elsevier eBooks (2023), pp. 235-253
Closed Access | Times Cited: 1
Arunima Deb, Neel Patel, Palak A. Patel, et al.
Elsevier eBooks (2023), pp. 235-253
Closed Access | Times Cited: 1
